Co-Diagnostics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $149 | $641 | $161 | $252 |
Gross Profit | -105 | 343 | -389 | -312 |
EBITDA | -9,883 | -7,341 | -9,928 | |
EBIT | -10,234 | -7,679 | -10,259 | |
Net Income | -11,031 | -9,696 | -7,599 | -9,312 |
Net Change In Cash | 149 | 641 | 161 | 252 |
Free Cash Flow | -8,303 | -7,403 | -5,302 | -8,892 |
Cash | 2,936 | 10,797 | 13,858 | 23,099 |
Basic Shares | 31,929 | 30,494 | 30,124 | 29,842 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $3,915 | $6,812 | $34,218 | $97,885 |
Gross Profit | 2,916 | 2,627 | 28,737 | 86,310 |
EBITDA | -36,204 | -41,475 | -10,308 | 46,400 |
EBIT | -37,581 | -42,706 | -11,621 | 46,064 |
Net Income | -37,639 | -35,332 | -14,238 | 36,658 |
Net Change In Cash | 3,915 | 6,812 | 34,218 | 97,885 |
Cost of Revenue | -65,633 | 45,630 | ||
Free Cash Flow | -29,903 | -23,447 | 5,141 | 40,411 |
Cash | 2,936 | 14,916 | 22,973 | 88,607 |
Basic Shares | 30,335 | 29,346 | 31,479 | 29,903 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.37 |
2024-09-30 | -$0.32 |
2024-06-30 | -$0.14 |
2024-03-31 | -$0.31 |
